The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death

Abstract Galvanic current has been emerging as a novel therapy to regenerate chronic tissue lesions, including musculoskeletal and dermatological lesions. Recently, the NLRP3 inflammasome and IL-1β release have been identified as a signaling pathway triggered upon galvanic current application. Howev...

Full description

Saved in:
Bibliographic Details
Main Authors: Alejandro Peñin-Franch, José Antonio García-Vidal, Ana Isabel Gómez, Pilar Escolar-Reina, Francesc Medina-Mirapeix, Pablo Pelegrín
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-81848-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850086172885254144
author Alejandro Peñin-Franch
José Antonio García-Vidal
Ana Isabel Gómez
Pilar Escolar-Reina
Francesc Medina-Mirapeix
Pablo Pelegrín
author_facet Alejandro Peñin-Franch
José Antonio García-Vidal
Ana Isabel Gómez
Pilar Escolar-Reina
Francesc Medina-Mirapeix
Pablo Pelegrín
author_sort Alejandro Peñin-Franch
collection DOAJ
description Abstract Galvanic current has been emerging as a novel therapy to regenerate chronic tissue lesions, including musculoskeletal and dermatological lesions. Recently, the NLRP3 inflammasome and IL-1β release have been identified as a signaling pathway triggered upon galvanic current application. However, the parameters for the clinical application of galvanic current remain subjective to the experience of the facultative in charge. In this study we used an in vitro model of macrophage culture and application of different combinations of the parameters of galvanic current to study IL-1β production and cell death. Increasing electric charge of galvanic current induces the release of IL-1β, but electric charges equal or higher to 144 mC also increase cell death. The release of IL-1β have a substantial variation within different electric charge of galvanic currents, being increased by decreasing the current and increasing the time of current application. Within the range of current intensities studied, the most optimal protocol for maximizing IL-1β release without inducing cell death was identified at electric charges equal to or near 144 mC, applied over a total duration of approximately 25 s. Our findings lay the groundwork for future in vivo studies assessing different electric charge of galvanic current, with the aim of yielding clinically relevant outcomes.
format Article
id doaj-art-1c8e5dc1c77e4324b47d94d8ecc972e1
institution DOAJ
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1c8e5dc1c77e4324b47d94d8ecc972e12025-08-20T02:43:33ZengNature PortfolioScientific Reports2045-23222024-12-0114111010.1038/s41598-024-81848-3The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell deathAlejandro Peñin-Franch0José Antonio García-Vidal1Ana Isabel Gómez2Pilar Escolar-Reina3Francesc Medina-Mirapeix4Pablo Pelegrín5Biomedical Research Institute of Murcia IMIB-Pascual ParrillaBiomedical Research Institute of Murcia IMIB-Pascual ParrillaBiomedical Research Institute of Murcia IMIB-Pascual ParrillaBiomedical Research Institute of Murcia IMIB-Pascual ParrillaBiomedical Research Institute of Murcia IMIB-Pascual ParrillaBiomedical Research Institute of Murcia IMIB-Pascual ParrillaAbstract Galvanic current has been emerging as a novel therapy to regenerate chronic tissue lesions, including musculoskeletal and dermatological lesions. Recently, the NLRP3 inflammasome and IL-1β release have been identified as a signaling pathway triggered upon galvanic current application. However, the parameters for the clinical application of galvanic current remain subjective to the experience of the facultative in charge. In this study we used an in vitro model of macrophage culture and application of different combinations of the parameters of galvanic current to study IL-1β production and cell death. Increasing electric charge of galvanic current induces the release of IL-1β, but electric charges equal or higher to 144 mC also increase cell death. The release of IL-1β have a substantial variation within different electric charge of galvanic currents, being increased by decreasing the current and increasing the time of current application. Within the range of current intensities studied, the most optimal protocol for maximizing IL-1β release without inducing cell death was identified at electric charges equal to or near 144 mC, applied over a total duration of approximately 25 s. Our findings lay the groundwork for future in vivo studies assessing different electric charge of galvanic current, with the aim of yielding clinically relevant outcomes.https://doi.org/10.1038/s41598-024-81848-3Percutaneous needle electrolysisGalvanic currentMacrophageInflammationIL-1βCell death
spellingShingle Alejandro Peñin-Franch
José Antonio García-Vidal
Ana Isabel Gómez
Pilar Escolar-Reina
Francesc Medina-Mirapeix
Pablo Pelegrín
The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death
Scientific Reports
Percutaneous needle electrolysis
Galvanic current
Macrophage
Inflammation
IL-1β
Cell death
title The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death
title_full The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death
title_fullStr The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death
title_full_unstemmed The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death
title_short The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death
title_sort total electric charge and time of application of galvanic currents to macrophages can optimize the release of il 1β with low cell death
topic Percutaneous needle electrolysis
Galvanic current
Macrophage
Inflammation
IL-1β
Cell death
url https://doi.org/10.1038/s41598-024-81848-3
work_keys_str_mv AT alejandropeninfranch thetotalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT joseantoniogarciavidal thetotalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT anaisabelgomez thetotalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT pilarescolarreina thetotalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT francescmedinamirapeix thetotalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT pablopelegrin thetotalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT alejandropeninfranch totalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT joseantoniogarciavidal totalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT anaisabelgomez totalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT pilarescolarreina totalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT francescmedinamirapeix totalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath
AT pablopelegrin totalelectricchargeandtimeofapplicationofgalvaniccurrentstomacrophagescanoptimizethereleaseofil1bwithlowcelldeath